Evaluating the Safety of PregSense™ and Compare Its Performance to CTG in Prenatal Monitoring of Pregnant Subjects

PregSense™ is a maternal-fetal monitor that non-invasively measures and displays fetal heart
rate, maternal hear rate and uterine contractions. This study will be performed to collect
and digitally record data from PregSense™ and the standard of care (CTG) in order to provide
evidence of safety and agreement between PregSense™ and the gold standard NST device.

Inclusion Criteria:

- Female age between 18-50

- Gestational age > 32 + 0 weeks

- Singleton gestation

- Ability to understand and sign informed consent

Exclusion Criteria:

- BMI (Body Mass Index) ≥ 45 and ≤15 prior pregnancy

- Multiple gestation

- Uncontrolled Hypertension

- Fetal Anomaly

- Subjects with skin problems in the abdominal area (such as flesh wounds, cuts in the
skin, skin rashes, etc.)

- Subjects with implanted electronic devices (pacemaker, defibrillator, etc.)

- Subjects who, in the judgement of the investigator, are likely to be non-compliant or
uncooperative during the study